Servier Việt Nam

About Servier Việt Nam

We are committed to therapeutic progress to serve patient needs. Servier is present in Vietnam since 1993. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. We are a leader in cardiology, our ambition is to become a recognized and innovative player in oncology. The corporate growth is driven by our constant search for innovation in five areas of excellence: cardiovascular, immune-inflammatory and neuropsychiatric disease, cancer and diabetes, as well as by our activities in high-quality generic drugs. All Group employees are driven by shared Values and guided by a common Vision. Together we share the passion of entrepreneurship and we are committed to therapeutic progress to serve patient needs. To report an adverse event, a product complaint or a medical question regarding a Servier product, please contact the website